Innovative Eyewear, Inc. (LUCY)
USD 5.55
(-7.65%)
USD 5.55
(-7.65%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | -119.32 Thousand USD | -111.99% |
| 2022 | -56.28 Thousand USD | -137.97% |
| 2021 | 148.25 Thousand USD | 958.5% |
| 2020 | -17.26 Thousand USD | -492.62% |
| 2019 | -2914.00 USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 55.17 Thousand USD | 693.79% |
| 2024 Q1 | 6951.00 USD | 103.86% |
| 2023 Q4 | -180.14 Thousand USD | -324.22% |
| 2023 FY | -119.32 Thousand USD | -111.99% |
| 2023 Q3 | 80.34 Thousand USD | 369.47% |
| 2023 Q2 | -29.81 Thousand USD | -389.73% |
| 2023 Q1 | 10.29 Thousand USD | 105.23% |
| 2022 Q2 | 43.24 Thousand USD | -41.86% |
| 2022 Q1 | 74.39 Thousand USD | 13.66% |
| 2022 FY | -56.28 Thousand USD | -137.97% |
| 2022 Q4 | -196.79 Thousand USD | -960.66% |
| 2022 Q3 | 22.86 Thousand USD | -47.13% |
| 2021 Q1 | 9340.00 USD | 158.09% |
| 2021 FY | 148.25 Thousand USD | 958.5% |
| 2021 Q2 | 32.65 Thousand USD | 249.64% |
| 2021 Q4 | 65.44 Thousand USD | 60.37% |
| 2021 Q3 | 40.81 Thousand USD | 24.97% |
| 2020 Q2 | 284.00 USD | 0.35% |
| 2020 FY | -17.26 Thousand USD | -492.62% |
| 2020 Q4 | -16.07 Thousand USD | -814.56% |
| 2020 Q3 | -1758.00 USD | -719.01% |
| 2020 Q1 | 283.00 USD | 0.0% |
| 2019 FY | -2914.00 USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 56.3 Million USD | 100.212% |
| AngioDynamics, Inc. | 154.69 Million USD | 100.077% |
| AtriCure, Inc. | 300.37 Million USD | 100.04% |
| Avinger, Inc. | 2 Million USD | 105.958% |
| Azenta, Inc. | 263.14 Million USD | 100.045% |
| BioLife Solutions, Inc. | 46.75 Million USD | 100.255% |
| The Cooper Companies, Inc. | 2.35 Billion USD | 100.005% |
| Daxor Corporation | 1.1 Million USD | 110.814% |
| Ekso Bionics Holdings, Inc. | 9.07 Million USD | 101.314% |
| Femasys Inc. | 691.9 Thousand USD | 117.247% |
| GlucoTrack, Inc. | -13 Thousand USD | -817.915% |
| Harvard Bioscience, Inc. | 60.86 Million USD | 100.196% |
| Hologic, Inc. | 2.22 Billion USD | 100.005% |
| ICU Medical, Inc. | 739.87 Million USD | 100.016% |
| Intuitive Surgical, Inc. | 4.72 Billion USD | 100.003% |
| KORU Medical Systems, Inc. | 16.7 Million USD | 100.714% |
| LeMaitre Vascular, Inc. | 127.04 Million USD | 100.094% |
| Innovative Eyewear, Inc. | -119.32 Thousand USD | -0.0% |
| Masimo Corporation | 1 Billion USD | 100.012% |
| Microbot Medical Inc. | -106 Thousand USD | -12.575% |
| Meihua International Medical Technologies Co., Ltd. | 33.09 Million USD | 100.361% |
| Merit Medical Systems, Inc. | 583.87 Million USD | 100.02% |
| Nephros, Inc. | 8.4 Million USD | 101.42% |
| NovoCure Limited | 381.05 Million USD | 100.031% |
| NEXGEL, Inc. | 619 Thousand USD | 119.278% |
| NEXGEL, Inc. | 619 Thousand USD | 119.278% |
| Singular Genomics Systems, Inc. | -558 Thousand USD | 78.615% |
| OraSure Technologies, Inc. | 179.42 Million USD | 100.067% |
| Pro-Dex, Inc. | 14.55 Million USD | 100.82% |
| Pulse Biosciences, Inc. | -1.2 Million USD | 90.114% |
| Predictive Oncology Inc. | 1.14 Million USD | 110.419% |
| Precision Optics Corporation, Inc. | 5.79 Million USD | 102.058% |
| QuidelOrtho Corporation | 1.49 Billion USD | 100.008% |
| Repligen Corporation | 315.22 Million USD | 100.038% |
| Sanara MedTech Inc. | 57.13 Million USD | 100.209% |
| STAAR Surgical Company | 252.65 Million USD | 100.047% |
| Sharps Technology, Inc. | -891.24 Thousand USD | 86.611% |
| Utah Medical Products, Inc. | 30.03 Million USD | 100.397% |
| DENTSPLY SIRONA Inc. | 2.08 Billion USD | 100.006% |
| Jin Medical International Ltd. | 6.78 Million USD | 101.759% |